Introduction
The local Shwartzman reaction (LSR) and reversed passive Arthus (RPA) reactions of rabbit skin have a strikingly similar gross pathology (localised in¯ammatory, haemorrhagic necrosis) but appear to be regulated by disparate mechanisms (Arthus, 1903; Shwartzman, 1928; Williams et al., 1986; Brozna, 1990; Rossi et al., 1992; Norman et al., 1994; 1996) . Traditionally, the LSR is produced by two injections of lipopolysaccharide (LPS), i.d. priming followed 18 ± 24 h later by i.v. challenge. In¯ammatory changes such as increased blood¯ow, oedema formation, leucocyte and platelet accumulation, and altered adhesion molecule expression occur in response to the priming injection of LPS while systemic challenge initiates events that lead to the intravascular coagulation and haemorrhagic necrosis at primed sites that characterize this reaction (Shwartzman, 1928; Movat et al., 1980; Argenbright & Barton, 1992; Norman et al., 1996) . It is believed that the LSR models disseminated intravascular coagulation (DIC) and associated multiple organ failure that can occur during sepsis (Brozna, 1990) .
The dermal Arthus reaction, also a haemorrhagic lesion, develops in the skin of sensitized animals after locally injected antigen forms immune complexes with circulating antibody. The related reversed passive Arthus reaction is produced when locally injected antibody forms immune complexes with i.v. injected antigen. Immune complex formation is important in many conditions including immune complex glomerulonephritis, serum sickness and farmer's lung where in¯ammation and damage to tissues occur by mechanisms similar to those seen in the RPA reaction.
Immune complexes and LPS both initiate the generation of various in¯ammatory mediators including complement fragments, platelet-activating factor (PAF), tumour necrosis factor-a, interleukin-1 and interleukin-8 which can in¯uence the accumulation and activation state of in¯ammatory cells including neutrophils Beaubien et al., 1990; Collins et al., 1991; von Uexkull et al., 1992; Nourshargh et al., 1994; and platelets Pons et al., 1992; Rossi et al., 1993) .
PAF induces oedema formation and accumulation of platelets in rabbit skin (Pons et al., 1992; Rossi et al., 1992; . Studies with PAF antagonists have implicated PAF as an important mediator of immune-complex mediated in¯amma-tion (Deacon et al., 1986; Williams et al., 1986; Issekutz & Szejda, 1986; 1989; Jancar et al., 1988; Warren et al., 1989; Pons et al., 1992; Rossi et al., 1992; Travares de Lima et al., 1992; Teixeira et al., 1994) . In particular, PAF antagonists administered intradermally or intravenously reduce oedema formation and platelet deposition in the RPA reaction in rabbit skin 1989; Williams et al., 1986; Pons et al., 1992; Rossi et al., 1992; . The PAF antagonist, L-659,989 has also been shown to reduce neutrophil accumulation in an RPA reaction of rabbit skin (Hellewell, 1990) .
A number of lines of evidence implicate PAF as an important mediator of responses to LPS. Thus, PAF, injected i.v., reproduces many of the features of clinical or experimental septic shock (Anderson et al., 1991; Qian et al., 1994) . PAF antagonists protect against LPS or bacteria-induced shock in dierent animal models (Terashita et al., 1983; Etienne et al., 1985; Toyofuku et al., 1986; Casals-Stenzel, 1987; Chang et al., 1987; Fletcher et al., 1989; Kuipers et al., 1994) and elevated PAF concentrations have been detected in the plasma of sepsis patients (Bussolino et al., 1987) . Furthermore, a recent phase II clinical trial indicated improved organ failure statistics in patients treated with a PAF antagonist (Froon et al., 1996) . The contribution of PAF to local responses to LPS such as the LSR is less well understood.
UK-74,505, a long acting and selective PAF antagonist (Cooper et al., 1990; Parry et al., 1994) has been used to demonstrate a role for PAF in oedema formation and platelet accumulation in the RPA reaction in the rabbit (Pons et al., 1992; Rossi et al., 1993) . Here we use UK-74,505 to extend our earlier observations regarding the RPA reaction and to study the role of PAF in in¯ammatory and haemorrhagic reactions induced by bacterial LPS.
Methods

Animals
New Zealand White rabbits (2.5 ± 3.5 kg) were bought from Regal, Sussex, U.K. All procedures described were approved by the Home Oce.
Isolation, and radiolabelling of rabbit neutrophils Neutrophils were isolated from rabbit blood as previously described (Haslett et al., 1987; Norman et al., 1996) . Brie¯y, citrated blood collected from the carotid artery of a donor rabbit was centrifuged at 300 g for 20 min. Platelet-rich plasma (PRP) was removed, under-layered with 3 ml 90% Percoll (Norman et al., 1996) and centrifuged at 2000 g for 20 min to produce platelet-poor plasma (PPP). Following 30 min dextran sedimentation of the pellet produced by the ®rst spin, leukocyte-rich supernatant was removed and centrifuged at 275 g for 6 min. The resultant pellet was re-suspended in PPP, layered onto discontinuous Percoll-plasma gradients and centrifuged for 40 min at 260 g. The neutrophil-rich band was collected and contaminating red blood cells (RBC) removed by hypotonic lysis. Unlabelled neutrophils were used in aggregation assays. For radiolabelling, rabbit neutrophils (498% pure) were suspended in 1 ± 2 ml of PPP and incubated with approximately 100 mCi 111 InCl 3 chelated to 2-mercaptopyridine-N-oxide (400 mg ml 71 ) for 15 min at room temperature. Cells were washed in PPP to remove unbound radiolabel and suspended in PPP. Each recipient rabbit received 5610 7 neutrophils in 3 ml PPP through a marginal ear vein.
Measurement of neutrophil aggregation
Rabbit neutrophils (10 7 cell ml 71 ) were kept at room temperature in Ca 2+ /Mg 2+ free buer (composition in mM: NaCl 138, KCl 2.7, Na 2 HPO 4 8.1, KH 2 PO 4 1.5 and HEPES 10). Twenty minutes before use, cells were warmed to 378C and CaCl 2 and MgCl 2 (®nal concentrations 1.0 mM and 0.7 mM, respectively) were added. Aggregation was assessed photometrically in a dual channel aggregometer (Chronolog 440 VS). Aliquots of neutrophil suspension (250 ml) were incubated for 5 min at 378C with continuous stirring at 700 r.p.m. and then stimulated with either PAF or leukotriene B 4 (LTB 4 ). Aggregation of platelets resulted in increased light transmission through the suspension. Responses which were allowed to develop for 3 min are expressed as a percentage of maximal aggregation induced by 10 76 M phorbol 12-myristate 13-acetate (PMA; Teixeira et al., 1995) . Buer alone was used as a reference. Where the eect of UK-74,505 on responses to LTB 4 and PAF was studied, antagonist was added to the neutrophil suspension 2 min before agonist stimulation.
Preparation and radiolabelling of rabbit platelets
Citrated blood collected from the carotid artery of a donor rabbit was centrifuged at 300 g for 20 min. PRP was removed, under-layered with 90% Percoll and centrifuged at 2000 g for 20 min to produce PPP and a layer of platelets at the plasmaPercoll interface. The platelets were harvested, suspended in 1 ± 2 ml of PPP and incubated with 100 mCi
111
InCl 3 chelated to 2-mercaptopyridine-N-oxide (400 mg ml 71 ) for 15 min at room temperature. Cells were washed three times in PPP to remove unbound radiolabel, and ®nally suspended in PPP at approximately 0.33610 9 platelets ml 71 (concentration determined with a coulter counter model ZM, Coulter Electronics Ltd, Luton, Bedfordshire). Recipient rabbits received 3 ml platelet suspension (i.e. 10 9 platelets) via a marginal ear vein.
Preparation and radiolabelling of RBC
Blood from a donor rabbit was centrifuged at 250 g for 20 min. One millilitre of RBC for each recipient rabbit was collected from the resultant pellet. Na 2 51 CrO 4 (0.5 mCi ml The RPA reaction and acute (4 h) in¯ammatory reactions in rabbit skin Rabbits were anaesthetized with sodium pentobarbitone (Sagatal, 15 mg kg 71 , i.v.) and the dorsal skin was shaved and marked out with 6 replicates of 12 ± 16 treatment sites according to a balanced site plan.
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In-neutrophils and [ 125 I]-human serum albumin were injected i.v. as markers of neutrophil accumulation and plasma protein leakage. UK-74,505 or vehicle was injected i.v. and allowed 10 min to circulate. LPS, Arthus antiserum (anti-bovine-g-globulin, BGG), PAF plus prostaglandin E 2 (PGE 2 ), bradykinin (BK) plus PGE 2 and zymosan-activated plasma (ZAP) were injected i.d. in 0.1 ml volumes. To initiate RPA reactions, the antigen BGG was injected i.v. at 5 mg kg
71
. Blood samples were collected into heparin 4 h after i.v. BGG and animals killed by an anaesthetic overdose. The dorsal skin was removed and skin sites excised with a 17 mm diameter punch. Radioactivity in skin sites was assessed by an automatic g-counter. Where neutrophil accumulation was measured the 111 In-count per neutrophil was determined, and used to express accumulated 111 In in skin sites as number of radiolabelled neutrophils. Where platelet accumulation was measured the 111 In-count per platelet was determined, and used to express accumulated 111 In in skin sites as number of radiolabelled platelets. Human serum albumin accumulation was expressed as ml plasma per skin site by dividing skin sample 125 I counts by 125 I counts in 1 ml of plasma.
The local Shwartzman reaction
Rabbits were anaesthetized with intramuscular ketamine (30 ± 35 mg kg
71
) and xylazine (2 ± 3 mg kg 71 ). The dorsal skin was shaved and marked out with 6 replicates of 5 treatment sites according to a balanced site plan. Vehicle saline and LPS from Salmonella typhosa were injected at concentrations giving 0, 1, 3.16, 10 and 31.6 mg per skin site. 51 Cr-labelled RBC and [
125 I]-human serum albumin were injected i.v. 20 h after priming. LSR were challenged as described (Norman et al., 1996) with 100 mg LPS from S. typhosa given intravenously at 20 and 22 h. At 24 h (4 h after ®rst challenge), blood samples were collected into heparin by cardiac puncture and animals killed by an overdose of sodium pentobarbitone. The dorsal skin was removed and skin sites excised with a 17 mm diameter punch. Radioactivity in skin sites was assessed in an automatic g counter. Accumulation of 51 Cr-labelled RBC was expressed as ml blood per skin site by dividing skin sample 51 Cr-counts by 51 Cr-counts in 1 ml whole blood. Human serum albumin accumulation was expressed as ml plasma per skin site by dividing skin sample 125 I-counts by 125 I-counts in 1 ml of plasma.
Materials
Arthus antiserum and zymosan-activated plasma (ZAP) were prepared as described by Rossi et al. (1992) 
Statistical analysis
Data are presented as mean+s.e.mean for the number of animals indicated. Data were analysed by two way analysis of variance. Signi®cant dierences (*P50.05, **P50.01) from the appropriate controls were determined by the NewmanKeuls procedure which allows for multiple comparisons. 
Results
Eect of UK-74,505 on neutrophil aggregation in vitro
Washed rabbit neutrophils when appropriately stirred and exposed to PAF or LTB 4 undergo a concentration-dependent homotypic aggregation, as assessed by increased light transmission (Figure 1a) . To con®rm the in vitro selectivity and potency of UK-74,505 we examined the eect of this compound on rabbit neutrophil aggregation induced by these lipid mediators. Figure 1b shows that neutrophil aggregation induced by 10 77 M PAF was competitively inhibited by UK-74,505. The highest concentration of UK-74,505 used (10
did not eect LTB 4 -induced aggregation.
Eect of UK-74,505 on oedema formation in response to mediators (4 h time course)
We next examined the speci®city and duration of action of UK-74,505 in vivo. Figure 2 shows 
Eect of UK-74,505 on neutrophil accumulation in the RPA reaction
The eect of UK-74,505 on neutrophil accumulation and oedema formation in the RPA reaction determined after a 4 h period in rabbit skin is shown in Figure 3 Eect of UK-74,505 on LSR priming and challenge Figure 5 shows the eect of UK-74,505 on LSR priming. Rabbits were given either vehicle or UK-74,505 (2 mg kg 71 , i.v.) 10 min before i.d. priming doses of LPS. Injections of 100 mg LPS were given i.v. at 20 and 22 h after priming to challenge the LSR. Haemorrhage (upper panel) and oedema formation (lower panel) were seen at primed skin sites 4 h after the ®rst challenge (i.e. 24 h after priming). The magnitude of these responses was dependent upon the priming dose of LPS. Haemorrhage and plasma leakage in the LSR were not aected by 505 given at the time of priming.
The eect of UK-74,505 given immediately before LSR challenge is shown in Figure 6 . Rabbits were primed with in- ; *) was given i.v. followed 10 min later by the ®rst LSR challenge (100 mg LPS, i.v.). A second challenge (100 mg LPS, i.v.) was given at 22 h. Animals were killed 24 h after i.d. injections (4 h after ®rst challenge), and haemorrhage and plasma protein leakage measured as detailed in the Methods section. Results are expressed as ml blood per skin site and ml plasma per skin site and presented as mean, with vertical lines showing s.e.mean, of n=4 experiments.
creasing doses of LPS. After 20 h either vehicle or UK-74,505 was given i.v., followed 10 min later by LSR challenge as described above. Haemorrhage and oedema formation produced at appropriately primed skin sites were not aected by UK-74,505 given i.v. before challenge.
Discussion
The results presented in this study demonstrate that neutrophil accumulation in the RPA reaction does not appear to be PAFdependent. This diers from our earlier ®ndings regarding the PAF-dependence of platelet accumulation in this response (Pons et al., 1992; Rossi et al., 1993) . Similarly, we found that platelet accumulation in response to LPS in rabbit skin is PAFdependent, whereas neutrophil accumulation is not. Our ®nding that UK-74,505 does not aect the LSR suggests that PAF is not an important mediator of this response.
A number of studies have implicated PAF as an important mediator of the RPA reaction. PAF antagonists administered locally or systemically have been shown to suppress oedema formation induced in an RPA reaction in the skin of rats and rabbits (Deacon et al., 1986; Williams et al., 1986; 1989; Rossi et al., 1992) and we demonstrated previously that platelet accumulation in the RPA reaction was also PAF-dependent (Pons et al., 1993; Rossi et al., 1993) . Whilst PAF antagonism has been widely studied as a possible treatment for septic shock, the role of PAF in local inammatory responses to LPS and in the LSR has not been addressed. In this study we used the potent and long-acting PAF antagonist UK-74,505 (Cooper et al., 1990; Parry et al., 1994) to extend our observations concerning the role of PAF in the RPA reaction and to determine what role, if any, PAF has in responses to LPS and in the LSR in rabbit skin.
In a previous study (Pons et al., 1992) we showed that UK-74,505 is a long-acting, potent and selective blocker of rabbit platelet PAF receptors both in vitro and in vivo. We also showed that UK-74,505 inhibits platelet accumulation and oedema formation in the RPA reaction and in certain other reactions of rabbit skin. Here, we have demonstrated that neutrophil aggregation induced by PAF, but not by LTB 4 , is competitively inhibited by UK-74,505, demonstrating that UK-74,505 is also an eective and selective blocker of neutrophil PAF receptors in vitro. By studying oedema formation in response to mediators (BK, ZAP and PAF) given at various times after injection of UK-74,505 we showed that UK-74,505 is selective for PAF and active in vivo for at least 4 h after its injection at the doses employed (0.5 mg kg 71 or 2 mg kg 71 ). PAF injected into rabbit skin in the presence of PGE 2 caused a marked oedema formation which was reduced to levels produced by PGE 2 alone in the presence of UK-74,505. In contrast, PAF caused little or no neutrophil accumulation in rabbit skin. It is important to note, however, that i.d. injected PAF may be rapidly metabolised and that the lack of eect may be due to failure to reach the correct site of action rather than lack of bioactivity per se. In agreement with our previous study (Pons et al., 1992) , oedema formation in the RPA reaction was signi®cantly reduced by 505 . However, at the same reaction sites were oedema formation in the RPA reaction was inhibited, no eect on neutrophil accumulation was observed. This ®nding is not consistent with data from a previous study showing that a PAF antagonist, L-659,989, reduced neutrophil accumulation in the RPA reaction in rabbit skin (Hellewell, 1990) . The disparity between our results and those previously obtained may re¯ect dierences in the selectivity of the antagonists used.
Platelet accumulation has been shown to be a component of the acute in¯ammatory response to killed E.Coli (Jeynes et al., 1989) and to LPS . Mechanisms underlying this platelet accumulation have not been determined. LPS injected into rabbit skin caused a dose-dependent platelet accumulation which was almost completely inhibited by UK-74,505 indicating an important role for PAF in this response.
This contrasts with observations made for the RPA reaction where UK-74,505 gave signi®cant but only partial inhibition of platelet accumulation (Pons et al., 1992) . LPS Induced little oedema formation in rabbit skin, suggesting that LPS-induced PAF is, in some way, able to produce platelet-accumulation without aecting plasma permeability. This phenomenon might relate to the magnitude or location of PAF generation. Previously, we hypothesized that qualitative dierences in PAF antagonist sensitivity between RPA reactions and responses to i.d injected immune complexes or zymosan might be due to such a phenomenon (Pons et al., 1992) .
Having determined that PAF is an important mediator of platelet accumulation in response to LPS, UK-74,505 was next used to investigate the role of PAF in the neutrophil accumulation associated with this response. LPS caused a marked accumulation of neutrophils which was not aected by treatment with UK-74,505 suggesting that PAF is not an important mediator of LPS-induced neutrophil accumulation in rabbit skin. It should be stressed that the above experiments tell us little about the behaviour of neutrophils once they have accumulated, only that they do accumulate. PAF may still be an important mediator of neutrophil responses in the above reactions, possibly mediating their activation. Recent experiments, in which intravital microscopy was used to visualise the circulation of rat mesentery, demonstrated that UK-74,505 inhibited extravasation of leucocytes induced by intraperitoneal interleukin-1 (Nourshargh et al., 1994) . Such a role for PAF in RPA reactions and in responses to LPS is not precluded by our experiments, as measurement of 111 Inlabelled neutrophil accumulation into skin sites does not distinguish between cells migrated into tissue and cells remaining adherent in blood vessels.
The possible role of PAF in either LSR priming or events that follow challenge in this reaction is not clear. Evidence that PAF may be an important mediator of some of the events associated with septic shock suggests that LPS-stimulated PAF generation may also be important for the development of the LSR. However, UK-74,505 which has been shown to be a potent and selective inhibitor of a number of PAF-dependent responses did not aect haemorrhage or plasma protein leakage in the LSR when given i.v. either immediately before priming injections of LPS, or 10 min before LSR challenge. The observation that UK-74,505 inhibits platelet accumulation in response to i.d. LPS, but not the LSR when given before priming injections suggests that LSR priming is both PAF-and platelet-independent. It is possible that platelet accumulation and other PAF-dependent responses to i.d. LPS are merely delayed by 505 and that platelet accumulation and priming continue when the antagonist is ®nally cleared. We consider this possibility unlikely, as the Shwartzman reaction is highly time-dependent and thus delaying the underlying controlling events would be expected to have profound eects on the haemorrhagic necrosis seen after challenge. The role of platelets in the LSR is a subject of controversy, with some studies showing that their presence is an absolute requirement for the Shwartzman reaction to occur (Margaretten & McKay, 1969) , or that, conversely, platelet depletion has no eect on the reaction (Levin & Clu, 1965) . Our ®ndings support the latter view. That UK-74,505 injected before LSR challenge had no eect on the subsequent appearance of haemorrhagic lesions at primed sites suggests that the events that follow LSR challenge occur independently of the high levels of circulating PAF found to result from i.v. injection of LPS (Doebber et al., 1985; Chang et al., 1987) .
In summary, our studies indicate that platelet accumulation in the RPA reaction and in response to i.d. LPS may occur through similar PAF-dependent mechanisms, while neutrophil accumulation in these responses occurs independently of PAF. In spite of our ®nding that platelet accumulation in response to i.d. LPS is PAF dependent, our studies have not indicated a role for PAF in the LSR. The pathology associated with severe, systemic bacterial infection is highly complex, and to be clinically useful a treatment needs to address as many of its features as possible. If the LSR is, as it is believed, a good model of the disseminated intravascular coagulation and associated organ damage that often accompany severe bacterial infection, then our results indicate that PAF antagonists might fail to address these important disease features.
